The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Advances in Temporal Lobe Epilepsy Research
AI in Neurology: What Tools Are Emerging?
B-Cell Therapy: When Is It Right for Our MS Patients?
Alzheimer’s Disease: What’s The Latest Research?
Investigating the Impact of Mobile Stroke Units
Investigating the Potential Link Between Epstein-Barr Virus & MS
Keys to Closing the Gender Gap in Stroke Trials
Diagnosing Mental Illness with the Perspectives Approach
Could T Cells Lead to New MS Treatments?
Seeking Out Symptoms of Broken Heart Syndrome
Treatment of Progressive MS: Why, Who, When, How
Giancarlo Comi, MD
Peer